1. Introduction {#sec1-viruses-11-01014}
===============

EqHV is one of 14 species belonging to the genus *Hepacivirus* in the family Flaviviridae \[[@B1-viruses-11-01014]\]. This hepatotropic virus, also referred to as canine hepacivirus, non-primate hepacivirus and hepacivirus A, represents the closest related genetic homologue of hepatitis C virus (HCV) \[[@B1-viruses-11-01014],[@B2-viruses-11-01014]\]. It is one of the novel viral agents, which has been associated with hepatitis in horses in recent years. EqHV infection typically results in subclinical hepatitis and transient, mild increases in liver-specific plasma biochemistry parameters \[[@B3-viruses-11-01014]\].

Prevalence studies have demonstrated a global distribution of EqHV. The virus has been detected in horse populations across six continents, in countries including the USA, Brazil, South Africa, New Zealand, Korea, Japan, China, Scotland, France, as well as Austria's neighboring countries Italy, Germany and Hungary \[[@B3-viruses-11-01014],[@B4-viruses-11-01014],[@B5-viruses-11-01014],[@B6-viruses-11-01014],[@B7-viruses-11-01014],[@B8-viruses-11-01014],[@B9-viruses-11-01014],[@B10-viruses-11-01014],[@B11-viruses-11-01014],[@B12-viruses-11-01014],[@B13-viruses-11-01014],[@B14-viruses-11-01014],[@B15-viruses-11-01014],[@B16-viruses-11-01014]\]. However, apart from a single case of vertical transmission \[[@B17-viruses-11-01014]\], natural routes of EqHV transmission remain elusive. Based on the frequent detection of EqHV RNA (prevalence up to 34.1%) \[[@B16-viruses-11-01014]\], EqHV antibodies (prevalence up to 83.7%) \[[@B4-viruses-11-01014]\] and the high EqHV prevalence in certain geographic regions and breeds \[[@B3-viruses-11-01014],[@B4-viruses-11-01014],[@B12-viruses-11-01014],[@B13-viruses-11-01014]\], vertical transmission is unlikely to be the only route of natural infection. Phylogenetic clustering of EqHV isolates from individual horses within their respective herds also suggests a horizontal route of transmission \[[@B17-viruses-11-01014]\]. Young horses subjected to intensive management practices appear to be particularly at risk \[[@B18-viruses-11-01014],[@B19-viruses-11-01014]\]. HCV is known to spread by venereal transmission \[[@B20-viruses-11-01014]\]. The spread of EqHV by the venereal route has been implicated in studies, which found the frequent occurrence of EqHV in a cohort of broodmares and breeding stallions \[[@B13-viruses-11-01014]\] and a high frequency of EqHV RNA in horses bred for reproduction purposes \[[@B18-viruses-11-01014]\]. The venereal transmission of EqHV remains speculative. However, comparable to HCV, experimental and iatrogenic transmission of EqHV by means of infected blood and blood products have been demonstrated \[[@B21-viruses-11-01014],[@B22-viruses-11-01014],[@B23-viruses-11-01014]\].

Many known flaviviruses are horizontally transmitted between hematophagous arthropods and vertebrate hosts \[[@B24-viruses-11-01014]\]. Examples include dengue virus, yellow fever virus (YFV), Japanese encephalitis virus (JEV), Zika virus (ZIKV), tick-borne encephalitis virus (TBEV), West Nile virus (WNV) and Usutu virus (USUV). Mosquito-borne viruses are transmitted by a vast range of mosquito species, depending primarily on the vector-competence of the mosquito species, the geographical region and susceptible vertebrate host species \[[@B24-viruses-11-01014]\].

The primary aim of this study was to investigate whether various mosquito species, present in areas of EqHV endemicity in horses, carry EqHV nucleic acid and may transmit the virus horizontally between horses. Mosquitoes were collected across Austria and analyzed for EqHV RNA. Concurrently, the occurrence of EqHV was investigated---for the first time---in the horse population of Austria. The geographical locations of analyzed mosquito pools and study horses' properties of origin were plotted on a map to determine proximity and compare EqHV statuses. Additionally, liver-specific plasma biochemistry parameters were compared between EqHV RNA-positive horses and EqHV RNA-negative control horses. Sequencing and phylogenetic analyses of Austrian EqHV strains were performed.

2. Materials and Methods {#sec2-viruses-11-01014}
========================

2.1. Study Design and Population {#sec2dot1-viruses-11-01014}
--------------------------------

In this cross-sectional study, serum and plasma samples were collected for surveillance purposes from 386 horses in eastern Austria between July and October 2017. Sampled horses included patients of the University of Veterinary Medicine Vienna (Vetmeduni) Equine Clinic (*n* = 58), teaching horses of the Vetmeduni (*n* = 50) and privately owned, clinically unremarkable horses enrolled voluntarily (*n* = 278). The sample population consisted of various breeds and included 156 mares, 187 geldings, 42 stallions and one horse with the sex undisclosed. The horses' ages ranged from 1 to 31 years (median age = 12.17 years). The geographic locations were recorded for the properties of origin of the horses.

Considering an estimated population of 120 000 horses in Austria, the sample size was calculated. The expected prevalence of horses positive for EqHV RNA was set to 3.6%, which is the average prevalence of two surveillance studies in horse populations of various breeds and ages, performed in Germany (*n* = 433 horses; RNA prevalence = 2.5%) \[[@B3-viruses-11-01014]\] and Italy (*n* = 1932 horses; RNA prevalence = 4.7 %) \[[@B6-viruses-11-01014]\], respectively. Given a confidence interval of 95%, a sample size of 54 horses was required. The expected prevalence of EqHV antibody-positive horses was set to 31.4%---the antibody prevalence detected in the same German surveillance study \[[@B3-viruses-11-01014]\]. Given a confidence interval of 95%, a sample size of 331 horses was required. Hence, the investigation of 386 horses was considered to be sufficient to estimate the prevalence of EqHV RNA and antibodies in Austrian horses. Sample size calculations were performed using Epitools Ausvet (epitools.ausvet.com.au/).

Data collection was approved by the Ethics Committee of the University of Veterinary Medicine Vienna, the Austrian Federal Ministry of Labor, Social Affairs, Health and Consumer Protection and the Austrian Federal Ministry of Education, Science and Research (study reference number BMWF- 68.205/0125-WF/V/3b/2017).

2.2. Mosquito Collection {#sec2dot2-viruses-11-01014}
------------------------

4039 mosquitoes collected in 2017 were pooled in 430 pools according to location, time of trapping and mosquito species. The mosquitoes were trapped across Austria and included both native and invasive species. In addition, 1004 mosquitoes were trapped in the 21^st^ Viennese district in August 2017, during a targeted mosquito and virus surveillance program following the identification of an USUV RNA-positive blood donor from that district \[[@B25-viruses-11-01014]\]. These mosquitoes were pooled in 104 pools. The mosquito collection of the 21^st^ district was included in the study because a high number of investigated horses originated from this district, in which the Vetmeduni is located. A small number of mosquitoes from northeast Italy (*n* = 295; 32 pools; mainly invasive species), collected between June and October 2017, were also included in the analysis. In total, 5338 mosquitoes in 566 pools were investigated for the presence of EqHV nucleic acid. The following species were represented: *Aedes albopictus*, *Aedes japonicus*, *Aedes koreicus*, *Anopheles claviger, Anopheles maculipennis, Anopheles plumbeus, Culex hortensis, Culex pipiens, Culiseta annulata* and *Ochlerotatus geniculatus*.

2.3. Laboratory Analysis {#sec2dot3-viruses-11-01014}
------------------------

### 2.3.1. Detection of EqHV RNA in Mosquito Pools {#sec2dot3dot1-viruses-11-01014}

Mosquito preparation was conducted as described previously \[[@B26-viruses-11-01014]\]. From each mosquito pool homogenate, 140 µL was processed by automated nucleic acid extraction employing a QIAamp 12 Viral RNA Mini QIAcube Kit (Qiagen, Germany) according to the manufacturer's instructions. Extracted RNA was transcribed into complementary deoxyribonucleic acid (cDNA) by applying the PrimeScriptRTMaster Mix Kit (TaKaRa, Kusatsu, Japan). All cDNA samples were stored at −20 °C before being used for RT-qPCR. For the SYBR Green based RT-qPCR, the SYBR^®^Premix Ex Taq™ II kit (TaKaRa, Kusatsu, Japan) was used, in combination with the previously described primers targeting the 5′ untranslated region (5′UTR) \[[@B5-viruses-11-01014]\]. A standard curve for the quantification of RNA copies was assessed by serial dilution of a plasmid containing the EqHV 5′UTR based on the EqHV isolate NPHV-NZP-1 (JQ434001.1). Measurement of fluorescence was conducted with a LightCycler 480 (Roche, Mannheim, Germany). The limit of detection for this RT-qPCR assay was determined to be 7.86 viral copies/µL of homogenate. RT-qPCR analysis of mosquito pool homogenates was performed by the Department of Molecular and Medical Virology, Ruhr-University Bochum, Germany.

### 2.3.2. Detection of EqHV RNA in Horse Serum {#sec2dot3dot2-viruses-11-01014}

Viral RNA was extracted from 200 µL of each horse´s serum using the QIAamp 96 Virus QIAcube HT Kit (Qiagen, Germany) according to the manufacturer´s instructions. For screening, EqHV-specific nucleic acids were detected by RT-qPCR using primers and probes as described previously \[[@B5-viruses-11-01014]\]. The RT-qPCR´s limit of quantification was established as 1.57 genome equivalents (GEs) per µL in the PCR reactions, which equates 7.85 × 10^2^ GEs per mL of horse serum. For absolute quantification, a serial dilution of a defined DNA plasmid standard was run in parallel with the positive samples. RT-qPCR analysis of horse serum samples was performed by the Institute of Virology, University of Veterinary Medicine Vienna, Austria.

### 2.3.3. Detection of Anti-EqHV Non-Structural Protein 3 (NS3)-Specific Antibodies in Horse Serum {#sec2dot3dot3-viruses-11-01014}

Serum samples were frozen between −20 °C and −80 °C prior to analysis for anti-EqHV non-structural protein 3 (NS3)-specific antibodies and shipped on dry ice to the laboratory in Germany. Samples were analyzed in duplicate for the presence of anti-EqHV NS3-specific antibodies, using the LIPS assay as described previously \[[@B27-viruses-11-01014]\]. Relative light units (RLU) were measured with a plate luminometer (LB 960 XS3; Berthold, Bad Wildbad, Germany). The threshold value, above which samples were regarded as antibody-positive, was calculated for each plate by using the mean value plus three standard deviations (SDs) of an EqHV-negative horse serum sample.

### 2.3.4. Plasma Biochemistry {#sec2dot3dot4-viruses-11-01014}

Plasma samples were frozen between −20 °C and −80 °C prior to analysis for GLDH, gamma-glutamyl transferase (GGT), bile acids and albumin concentrations at the Central Laboratory of the University of Veterinary Medicine Vienna. These parameters were measured in plasma samples of all EqHV RT-qPCR-positive horses, as well as in plasma samples of EqHV RT-qPCR-negative control horses (*n* = 45). The control horses were randomly selected from the group of privately owned, clinically unremarkable horses enrolled voluntarily. The laboratory's reference ranges were used for data analysis.

2.4. Data Analysis {#sec2dot4-viruses-11-01014}
------------------

Plasma biochemistry results were assessed for normality using the Shapiro Wilk test. The independent samples *t*-test was used to compare normally distributed parameters. The Mann--Whitney U test was used to compare non-normally distributed parameters. A 95% confidence interval was set and *p* ≤ 0.05 was considered statistically significant. Statistical analysis was performed using IBM SPSS Statistics 24 and the applicable figure was generated using Graph Pad Prism 5.

2.5. Sequencing and Phylogenetic Analyses {#sec2dot5-viruses-11-01014}
-----------------------------------------

Sixteen EqHV RNA-positive samples were used for sequence analyses. Nested PCRs targeting parts of the 5′UTR, NS3 and NS5B domains were conducted as previously described \[[@B6-viruses-11-01014],[@B10-viruses-11-01014]\] and sent for Sanger sequencing. Previously published complete genome sequences of EqHV and additional sequences of six isolates, which originated in France \[[@B12-viruses-11-01014]\], were retrieved from the GenBank database. All sequences were aligned with MUSCLE and primer sequences were deleted. Phylogenetic analyses were conducted by using the maximum-likelihood method by MEGA7 \[[@B28-viruses-11-01014]\] based on the general time reversible model \[[@B29-viruses-11-01014]\]. Gamma distributed with invariant sites (G + I) was set for rates among sites with a number of six discrete gamma categories. Bootstrap replicates were set to 500. All sequences were uploaded to the NCBI database with accession numbers (MN475754 - MN475783).

3. Results {#sec3-viruses-11-01014}
==========

3.1. Detection of EqHV RNA in Mosquito Pools {#sec3dot1-viruses-11-01014}
--------------------------------------------

No EqHV RNA was detected in any of the mosquito pools analyzed. The geographic locations of mosquito collection sites are indicated in [Figure 1](#viruses-11-01014-f001){ref-type="fig"}.

3.2. Detection of EqHV RNA in Horse Serum {#sec3dot2-viruses-11-01014}
-----------------------------------------

EqHV RNA was detectable in 4.15% of serum samples (16/386). Viral loads in 11 of the samples ranged from 1 × 10^3^ to 9 × 10^6^ GEs per mL serum. Five horses showed RT-qPCR signals, which were below the assay's level of quantification (\<7.9 × 10^2^ GEs/mL serum). The 16 RT-qPCR-positive horses originated from 12 different properties, with between one and four RT-qPCR-positive horses per property ([Table 1](#viruses-11-01014-t001){ref-type="table"}). The geographic locations of these properties are indicated in [Figure 1](#viruses-11-01014-f001){ref-type="fig"}.

3.3. Detection of Anti-EqHV NS3-Specific Antibodies in Horse Serum {#sec3dot3-viruses-11-01014}
------------------------------------------------------------------

The antibody prevalence in the study population was 45.9%, with 177 of the 386 samples antibody-positive. Based on the horses' EqHV infection-state, the samples could be assigned to four categories: antibody-negative and RNA-negative (Abs--/RNA--); antibody-positive and RNA-negative (Abs+/RNA--); antibody-positive and RNA-positive (Abs+/RNA+) and antibody-negative and RNA-positive (Abs--/RNA+; [Table 1](#viruses-11-01014-t001){ref-type="table"}). Two hundred and six samples (53.37%) tested negative for both EqHV antibodies and RNA. One hundred and sixty-four samples (42.49%) contained only antibodies, but no RNA. Thirteen samples (3.37%) contained both antibodies and RNA. Three samples (0.78%) contained only RNA, but no antibodies.

3.4. Plasma Biochemistry {#sec3dot4-viruses-11-01014}
------------------------

EqHV RT-qPCR-positive horses (*n* = 16) had significantly higher plasma GLDH concentrations (*p* = 0.013) compared to EqHV RT-qPCR-negative control horses (*n* = 45; [Table 2](#viruses-11-01014-t002){ref-type="table"}, [Figure S1](#app1-viruses-11-01014){ref-type="app"}). All three of the EqHV RT-qPCR-positive horses which had GLDH levels above the laboratory reference range, were also EqHV antibody-positive (Abs+/RNA+). Two of these three horses were privately owned, clinically unremarkable horses enrolled voluntarily and one was admitted to the Vetmeduni Equine Clinic for follow-up examination, after a traumatic fracture of the fourth metatarsal bone. The horse had received tetanus antiserum two months before sample collection, following the acute trauma. Clinical findings did not give any indication for elevation of GLDH concentrations in this patient. All three of the horses which were acutely infected with EqHV (Abs--/RNA+), had GLDH levels well below the upper normal limit of the laboratory reference range. GGT, bile acids and albumin concentrations did not differ significantly between EqHV RT-qPCR-positive horses and EqHV RT-qPCR-negative control horses (*p* \> 0.05; [Table 2](#viruses-11-01014-t002){ref-type="table"}).

3.5. Sequence and Phylogenetic Analyses {#sec3dot5-viruses-11-01014}
---------------------------------------

For a molecular characterization of the EqHV positive samples, three nested PCRs were performed to target different conserved regions of the viral genome. Most likely as a result of variation in the viral load of samples, we were able to recover 12/16 partial 5′UTR sequences, 7/16 partial NS3 sequences and 11/16 partial NS5B sequences ([Table 3](#viruses-11-01014-t003){ref-type="table"}).

Phylogenetic analysis based on partial NS5B sequences revealed only minor genetic distances between Austrian samples and previously published samples ([Figure 2](#viruses-11-01014-f002){ref-type="fig"}). Similarly, phylogenetic trees based on the 5′UTR ([Figure S2](#app1-viruses-11-01014){ref-type="app"}) and on NS3 ([Figure S3](#app1-viruses-11-01014){ref-type="app"}) visualize only minor differences between the sequences.

4. Discussion {#sec4-viruses-11-01014}
=============

The EqHV carrier-state of a large population of native and invasive mosquito species, collected across a large geographic area---the entire Austria and a small part of Italy---was investigated. This study also represents the first surveillance for EqHV in the horse population of Austria. The EqHV antibody prevalence (45.9%) and RNA prevalence (4.15%) detected in this population of Austrian horses were within previously reported ranges \[[@B4-viruses-11-01014],[@B16-viruses-11-01014],[@B30-viruses-11-01014]\]. Despite the frequently detected evidence of EqHV infection in the equine study population, no indication of viral nucleic acid was found in mosquito populations throughout Austria and northeast Italy.

Mosquito surveillance programs were initiated in Austria in 2011, with the aim of detecting invasive mosquito species \[[@B31-viruses-11-01014],[@B32-viruses-11-01014]\] and investigating the variety of viruses, which mosquitoes may carry and transmit to vertebrate hosts. Particularly the flaviviruses WNV and USUV have been detected \[[@B26-viruses-11-01014],[@B33-viruses-11-01014],[@B34-viruses-11-01014],[@B35-viruses-11-01014],[@B36-viruses-11-01014],[@B37-viruses-11-01014]\]. For the current study, nucleic acid extracts from the entire 2017 mosquito-collection were investigated for the presence of EqHV RNA. The vast majority of mosquitoes were collected between June and October 2017, coinciding with the time of blood collection from the horses (July to October 2017). All mosquito species native to Austria were represented in the collection, as well as a large number of individuals from the invasive species *Aedes japonicus*. *A. japonicus* is rapidly dispersing in Austria \[[@B31-viruses-11-01014]\], and was shown to be a flavivirus vector \[[@B35-viruses-11-01014]\].

Mosquito-borne flaviviruses replicate within the invertebrate vector during the extrinsic incubation period---the time between uptake of an infectious blood meal by a female mosquito and subsequent viral transmission to the host \[[@B24-viruses-11-01014]\]. A small percentage of infected female mosquitoes typically overwinter in frost-free areas, resulting in survival of the flavivirus \[[@B38-viruses-11-01014]\]. Vertical transmission of flaviviruses is also frequently observed in infected female mosquitoes \[[@B26-viruses-11-01014]\]. During the course of evolution, certain mosquito species developed "vector competence" for certain viruses. It was therefore essential to investigate a spectrum of mosquito species for the presence of EqHV RNA, since it is not known which mosquito species could be competent vectors for EqHV transmission. A large number of mosquito pools (*n* = 566), consisting of 5338 individuals from various species, representing five mosquito genera (*Aedes* spp., *Anopheles* spp., *Culex* spp., *Culiseta* spp. and *Ochlerotatus* spp.) contained no EqHV RNA. Based on these findings, mosquitoes are unlikely to play a role as vectors of EqHV.

Comparable numbers of Austrian mosquitoes enabled us to determine the minimal infection rate (MIR) of WNV in previous investigations \[[@B36-viruses-11-01014]\]. These results were in accordance with Czech and Hungarian studies, in which WNV-positive mosquitoes were detected in four of 650 pools \[[@B39-viruses-11-01014]\] and in three of 645 pools \[[@B40-viruses-11-01014]\], respectively. However, in areas with documented human or animal flavivirus infections, significantly higher numbers of mosquitoes were infested, as shown in \[[@B26-viruses-11-01014]\] and \[[@B36-viruses-11-01014]\] for WNV, and in \[[@B35-viruses-11-01014]\] for USUV. We are therefore confident that the number of investigated mosquitoes was sufficient to also detect other flaviviruses.

Similar to HCV, transmission by means of infected blood and blood products has been demonstrated for EqHV \[[@B21-viruses-11-01014],[@B23-viruses-11-01014]\]. Experimental infections of horses have been performed by intravenous administration of various volumes (range from 5 mL to 500 mL) of serum or plasma with varying viral loads (range from 3.92 × 10^3^ RNA copies/mL to 7.78 × 10^6^ RNA copies/mL) \[[@B21-viruses-11-01014],[@B23-viruses-11-01014]\]. Considering this proven route of EqHV transmission, it remains to be determined whether EqHV can be mechanically transmitted by other hematophagous insects. The family Tabanidae (horse flies) is of particular importance as mechanical vectors of viruses such as equine infectious anemia (EIA) \[[@B41-viruses-11-01014]\]. Painful bites, large lesions, persistent feeding behavior and the volume of blood left on their large mouthparts favors mechanical transmission \[[@B42-viruses-11-01014]\]. The volume of blood retained on the mouthparts of a horse fly is approximately 5 to 25 nL \[[@B41-viruses-11-01014],[@B43-viruses-11-01014]\]. Viral load in the blood of the host plays an important role in successful mechanical transmission of viruses. The minimum infectious dose of EqHV has not yet been determined.

Natural and experimental EqHV infections typically result in transient elevation of concentrations of liver-specific enzymes, indicative of hepatic inflammation. Increased GLDH, sorbitol dehydrogenase (SDH), GGT and aspartate aminotransferase (AST) levels have been reported \[[@B3-viruses-11-01014],[@B21-viruses-11-01014],[@B23-viruses-11-01014],[@B44-viruses-11-01014]\]. The increased plasma GLDH concentrations in EqHV RT-qPCR-positive horses are consistent with hepatocellular damage observed on liver histopathology of EqHV-infected horses \[[@B21-viruses-11-01014]\]. Although plasma GLDH concentrations were significantly higher in EqHV RNA-positive horses compared to EqHV RNA-negative horses, the GLDH values of the majority of EqHV RNA-positive individuals were still within the laboratory reference range. Therefore, potential cases of EqHV should not only be monitored for liver-specific enzyme concentrations above references values, but also for deviations of enzyme concentrations from the individual horse's baseline values. The timing of sampling is also of importance, with previous studies demonstrating that elevations in concentration of liver-specific enzymes typically do not occur during the acute phase of infection, but rather coincides with seroconversion \[[@B3-viruses-11-01014],[@B21-viruses-11-01014]\]. Our findings are in accordance with this data.

In accordance with findings from other regions, the phylogenetic analyses revealed high similarity at nucleotide sequence-level of EqHV circulating in Austria, compared to other countries \[[@B4-viruses-11-01014],[@B6-viruses-11-01014],[@B10-viruses-11-01014]\].

5. Conclusions {#sec5-viruses-11-01014}
==============

Despite evidence of EqHV infection being frequently detected in Austrian horses, no indication of viral nucleic acid was found in mosquito populations throughout the country. Consequently, mosquitoes are unlikely to play a role as vectors of this flavivirus. Nucleotide sequence differences between EqHV in Austria compared to EqHV of other origins are minor.

We gratefully acknowledge Bernhard Seidel (Technical Office of Ecology and Landscape Assessment, Persenbeug, Austria) for trapping and determination of the mosquitoes; Alexander Tichy (University of Veterinary Medicine Vienna) for assistance with statistical analysis of data; Peter D. Burbelo (NIH, Maryland, USA) for providing the Renilla-luciferase-NS3 fusion plasmid. We would like to thank all members of the Department of Molecular and Medical Virology at the Ruhr-University Bochum and especially Rosemarie Bohr, Regina Bütermann, Monika Kopytkowski, Klaus Sure, and Ute Wiegmann-Misiek for technical support. Open Access Funding by the University of Veterinary Medicine Vienna.

The following are available online at <https://www.mdpi.com/1999-4915/11/11/1014/s1>, Figure S1: Plasma GLDH concentrations of EqHV RT-qPCR-positive horses (n = 16) and EqHV RT-qPCR-negative control horses (n = 45), Figure S2: Maximum-likelihood phylogeny based on partial 5'UTR sequences of EqHV, Figure S3: Maximum-likelihood phylogeny based on partial NS3 sequences of EqHV.
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![Geographical locations of sampling sites. A map of Austria indicating mosquito collection sites and the properties of origin of sampled horses. Green mosquito-icons each represents the collection site of a minimum of one mosquito pool. Magenta horse-icons each represents a property where at least one horse tested equine hepacivirus (EqHV) RNA-positive, regardless of the EqHV antibody-status of the horses on these properties. Blue horse-icons each represents a property where all horses tested EqHV RNA-negative, but at least one horse tested EqHV antibody-positive. Black horse-icons each represents a property where all horses tested EqHV RNA-negative, as well as EqHV antibody-negative.](viruses-11-01014-g001){#viruses-11-01014-f001}

![Maximum-likelihood phylogeny based on partial NS5B sequences of EqHV. In addition to sequences obtained from Austrian horses, the phylogenetic tree contains previously published complete genome sequences of EqHV retrieved from the GenBank database, as well as sequences of six isolates, which originated in France \[[@B12-viruses-11-01014]\]. Different samples are identified with their accession number, country of origin and year of sampling or, if not applicable, year of publication. The analysis involved 45 nucleotide sequences. All positions containing gaps and missing data were eliminated, whereby a total of 258 positions were included in the final dataset. Bootstrap values \<70% are not shown. The scale bar represents the number of substitutions per site. Black circles indicate samples obtained in this study.](viruses-11-01014-g002){#viruses-11-01014-f002}

viruses-11-01014-t001_Table 1

###### 

Information pertaining to the 12 properties where EqHV RNA-positive horses were identified, including the EqHV infection-state of the sampled populations.

  Property    EqHV Infection-State                                                                           
  ----------- ---------------------- --------- ----------- --------- ----------- -------- ---------- ------- ----------
  1           12                     4         33.33       7         58.33       1        8.33       0       0.00
  2           10                     4         40.00       5         50.00       1        10.00      0       0.00
  3           20                     13        65.00       6         30.00       1        5.00       0       0.00
  4           21                     7         33.33       10        47.62       3        14.29      1       4.76
  5           14                     2         14.29       11        78.57       1        7.14       0       0.00
  6           32                     16        50.00       14        43.75       1        3.13       1       3.13
  7           3                      1         33.33       1         33.33       1        33.33      0       0.00
  8           20                     13        65.00       6         30.00       1        5.00       0       0.00
  9           13                     7         53.85       5         38.46       1        7.69       0       0.00
  10          50                     34        68.00       15        30.00       0        0.00       1       2.00
  11          1                      0         0.00        0         0.00        1        100        0       0.00
  12          1                      0         0.00        0         0.00        1        100        0       0.00
  All other   189                    105       55.56       84        44.44       0        0.00       0       0.00
  **Total**   **386**                **206**   **53.37**   **164**   **42.49**   **13**   **3.37**   **3**   **0.78**

viruses-11-01014-t002_Table 2

###### 

Specifications of the liver-specific biochemistry parameters glutamate dehydrogenase (GLDH), gamma-glutamyl transferase (GGT), bile acids and albumin measured in plasma samples of all EqHV RT-qPCR-positive horses (*n* = 16), as well as EqHV RT-qPCR-negative control horses (*n* = 45).

  Parameter (Reference Range)         GLDH (\<13 U/L)            GGT (\<30 U/L)             Bile acids (\<20 umol/L)   Albumin (2.4--4.5 g/dl)                                     
  ----------------------------------- -------------------------- -------------------------- -------------------------- ------------------------------ ------- ------- ------------ ------------
  ***n***                             16                         45                         16                         45                             16      45      16           45
  **Range (min--max)**                1.81--67.45                1.44--42.54                4--61                      1--42                          3--19   2--11   2.69--3.25   1.99--4.41
  **Normal distribution**             No                         No                         No                         No                             No      No      Yes          Yes
  **Median**                          4.84                       2.78                       14.5                       12                             5       5       3.04         2.98
  **Mean**                            12.98                      4.83                       16.13                      13.33                          5.81    5.53    3.03         3.04
  **Standard deviation**              20.27                      6.83                       13.27                      7.92                           3.94    2.16    0.16         0.52
  **Parametric/Nonparametric test**   The Mann--Whitney U test   The Mann--Whitney U test   The Mann--Whitney U test   Independent samples *t*-test                                
  ***p*-value**                       *p* = 0.013 \*             *p* = 0.434                *p* = 0.659                *p* = 0.855                                                 

\* EqHV RT-qPCR-positive horses had significantly higher plasma GLDH concentrations (*p* \< 0.05) compared to EqHV RT-qPCR-negative control horses.

viruses-11-01014-t003_Table 3

###### 

The newly identified sequences which were submitted to NCBI and assigned with accession numbers. n.a.---not available.

  Isolate   Accession Numbers              
  --------- ------------------- ---------- ----------
  N40-17    MN475754            MN475766   MN475773
  N87-17    MN475755            MN475767   MN475774
  N107-17   MN475756            MN475768   MN475775
  N147-17   MN475757            MN475769   MN475776
  N154-17   MN475758            MN475770   MN475777
  N201-17   MN475759            n.a.       MN475778
  N234-17   MN475760            MN475771   MN475779
  N235-17   MN475761            MN475772   MN475780
  N265-17   MN475762            n.a.       MN475781
  N351-17   MN475763            n.a.       MN475782
  N364-17   MN475764            n.a.       MN475783
  N403-17   MN475765            n.a.       n.a.
